rs765562932
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001182.5(ALDH7A1):c.154G>C(p.Glu52Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000618 in 1,457,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001182.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH7A1 | NM_001182.5 | c.154G>C | p.Glu52Gln | missense_variant | Exon 1 of 18 | ENST00000409134.8 | NP_001173.2 | |
ALDH7A1 | NM_001201377.2 | c.70G>C | p.Glu24Gln | missense_variant | Exon 1 of 18 | NP_001188306.1 | ||
ALDH7A1 | NM_001202404.2 | c.154G>C | p.Glu52Gln | missense_variant | Exon 1 of 16 | NP_001189333.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000370 AC: 9AN: 243176Hom.: 0 AF XY: 0.0000304 AC XY: 4AN XY: 131620
GnomAD4 exome AF: 0.00000618 AC: 9AN: 1457380Hom.: 0 Cov.: 32 AF XY: 0.00000552 AC XY: 4AN XY: 724534
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Pyridoxine-dependent epilepsy Uncertain:2
- -
This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 52 of the ALDH7A1 protein (p.Glu52Gln). This variant is present in population databases (rs765562932, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ALDH7A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 465324). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ALDH7A1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.154G>C (p.E52Q) alteration is located in exon 1 (coding exon 1) of the ALDH7A1 gene. This alteration results from a G to C substitution at nucleotide position 154, causing the glutamic acid (E) at amino acid position 52 to be replaced by a glutamine (Q). Based on data from the Genome Aggregation Database (gnomAD) database, the ALDH7A1 c.154G>C alteration was observed in <0.01% (9/243176) of total alleles studied, with a frequency of 0.03% (9/34050) in the Latino subpopulation. This amino acid position is not well conserved in available vertebrate species. The p.E52Q alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at